1. Pfizer Shutters Key South San Francisco Research Site in Strategic R&D Pullback
Pfizer is closing its South San Francisco research site, a significant retreat from a major biotech hub. The move signals a strategic realignment of the pharmaceutical giant's R&D footprint, directly impacting its presence in the heart of the Bay Area's innovation corridor. This closure is part of a broader cost-cuttin...